$BBIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BridgeBio Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BridgeBio Pharma, Inc.. Get notifications about new insider transactions in BridgeBio Pharma, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 02 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 0.34 | 4,000 | 1,360 | 19,823 | 15.8 K to 19.8 K (+25.28 %) |
Jul 02 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 0.16 | 6,000 | 960 | 15,823 | 9.8 K to 15.8 K (+61.08 %) |
Jun 25 2020 | BBIO | BridgeBio Pharma, ... | Scott Randal W | Director | Option Exercise | A | 32.62 | 101,223 | 3,301,894 | 101,223 | |
Jun 25 2020 | BBIO | BridgeBio Pharma, ... | SAUNDERS BRENT L | Director | Option Exercise | A | 32.62 | 101,223 | 3,301,894 | 101,223 | |
Jun 25 2020 | BBIO | BridgeBio Pharma, ... | Scott Randal W | Director | Option Exercise | A | 32.62 | 101,223 | 3,301,894 | 101,223 | |
Jun 25 2020 | BBIO | BridgeBio Pharma, ... | SAUNDERS BRENT L | Director | Option Exercise | A | 32.62 | 101,223 | 3,301,894 | 101,223 | |
Jun 25 2020 | BBIO | BridgeBio Pharma, ... | Lo Andrew | Director | Option Exercise | A | 32.62 | 101,223 | 3,301,894 | 101,223 | |
Jun 10 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Sell | S | 30.05 | 100 | 3,005 | 260,293 | 260.4 K to 260.3 K (-0.04 %) |
Jun 10 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Sell | S | 30.00 | 506 | 15,180 | 260,393 | 260.9 K to 260.4 K (-0.19 %) |
Jun 10 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 30.01 | 10,600 | 318,125 | 2,308,842 | 2.3 M to 2.3 M (-0.46 %) |
Jun 10 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 30.00 | 2,000 | 60,002 | 305,116 | 307.1 K to 305.1 K (-0.65 %) |
Jun 05 2020 | BBIO | BridgeBio Pharma, ... | YAU YI CHING | Chief Accounting Of ... | Option Exercise | A | 0.00 | 6,383 | 0 | 6,383 | |
Jun 05 2020 | BBIO | BridgeBio Pharma, ... | YAU YI CHING | Chief Accounting Of ... | Option Exercise | A | 28.86 | 45,931 | 1,325,569 | 45,931 | |
Jun 05 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Option Exercise | A | 0.00 | 27,356 | 0 | 27,356 | |
Jun 05 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Option Exercise | A | 28.86 | 196,850 | 5,681,091 | 196,850 | |
Jun 05 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 30.04 | 1,600 | 48,072 | 307,116 | 308.7 K to 307.1 K (-0.52 %) |
Jun 05 2020 | BBIO | BridgeBio Pharma, ... | Stolz Brian M. | Chief Operating Off ... | Option Exercise | A | 0.00 | 25,532 | 0 | 25,532 | |
Jun 05 2020 | BBIO | BridgeBio Pharma, ... | Stolz Brian M. | Chief Operating Off ... | Option Exercise | A | 28.86 | 183,727 | 5,302,361 | 183,727 | |
Jun 05 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Option Exercise | A | 0.00 | 82,069 | 0 | 82,069 | |
Jun 05 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Option Exercise | A | 28.86 | 590,551 | 17,043,302 | 590,551 | |
Jun 05 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 30.05 | 5,930 | 178,173 | 2,319,442 | 2.3 M to 2.3 M (-0.26 %) |
Jun 04 2020 | BBIO | BridgeBio Pharma, ... | Cook Jennifer E. | Director | Option Exercise | A | 29.00 | 112,422 | 3,260,238 | 112,422 | |
Jun 04 2020 | BBIO | BridgeBio Pharma, ... | HOMCY CHARLES J | Chairman of Pharmac ... | Option Exercise | A | 29.00 | 112,422 | 3,260,238 | 112,422 | |
Jun 04 2020 | BBIO | BridgeBio Pharma, ... | MOMTAZEE JAMES C | Director | Option Exercise | A | 29.00 | 112,422 | 3,260,238 | 112,422 | |
Jun 04 2020 | BBIO | BridgeBio Pharma, ... | Satvat Ali J. | Director | Option Exercise | A | 29.00 | 112,422 | 3,260,238 | 112,422 | |
Jun 04 2020 | BBIO | BridgeBio Pharma, ... | SCHELLER RICHARD H | See Remarks | Option Exercise | A | 29.00 | 112,422 | 3,260,238 | 112,422 | |
Jun 04 2020 | BBIO | BridgeBio Pharma, ... | AGUIAR ERIC | Director | Option Exercise | A | 29.00 | 112,422 | 3,260,238 | 112,422 | |
Jun 03 2020 | BBIO | BridgeBio Pharma, ... | Sinha Uma | Chief Scientific Of ... | Option Exercise | A | 0.00 | 7,500 | 0 | 7,500 | |
Jun 03 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 29.71 | 8,709 | 258,711 | 2,325,372 | 2.3 M to 2.3 M (-0.37 %) |
Jun 03 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 29.13 | 71,291 | 2,076,678 | 2,334,081 | 2.4 M to 2.3 M (-2.96 %) |
Jun 01 2020 | BBIO | BridgeBio Pharma, ... | KKR Genetic Disorder L.P. | Sell | S | 33.39 | 2,389,690 | 79,791,749 | 34,510,971 | 36.9 M to 34.5 M (-6.48 %) | |
May 27 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | M | 1.05 | 18,365 | 19,283 | 0 | |
May 27 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Buy | M | 1.05 | 18,365 | 19,283 | 264,268 | 245.9 K to 264.3 K (+7.47 %) |
May 21 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | A | 1.05 | 18,365 | 19,283 | 18,365 | |
May 21 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | A | 2.29 | 19,271 | 44,131 | 19,271 | |
May 21 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | A | 1.05 | 45,027 | 47,278 | 45,027 | |
May 21 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | A | 4.22 | 13,932 | 58,793 | 13,932 | |
May 21 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | A | 1.65 | 3,351 | 5,529 | 3,351 | |
May 21 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | A | 4.13 | 7,778 | 32,123 | 7,778 | |
May 21 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | A | 0.16 | 39,487 | 6,318 | 39,487 | |
May 21 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | A | 0.28 | 1,019 | 285 | 1,019 | |
May 21 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | A | 0.28 | 7,335 | 2,054 | 7,335 | |
May 21 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | A | 0.00 | 205,000 | 0 | 205,000 | |
May 21 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Grant | A | 0.00 | 83,541 | 0 | 245,903 | 162.4 K to 245.9 K (+51.45 %) |
May 21 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | A | 0.34 | 49,766 | 16,920 | 49,766 | |
May 21 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | A | 0.16 | 74,042 | 11,847 | 74,042 | |
May 21 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | A | 1.25 | 1,082 | 1,353 | 1,082 | |
May 21 2020 | BBIO | BridgeBio Pharma, ... | Sinha Uma | Chief Scientific Of ... | Option Exercise | A | 3.35 | 3,022 | 10,124 | 3,022 | |
May 21 2020 | BBIO | BridgeBio Pharma, ... | Sinha Uma | Chief Scientific Of ... | Option Exercise | A | 0.34 | 49,765 | 16,920 | 49,765 | |
May 21 2020 | BBIO | BridgeBio Pharma, ... | Sinha Uma | Chief Scientific Of ... | Option Exercise | A | 0.16 | 49,361 | 7,898 | 49,361 | |
May 21 2020 | BBIO | BridgeBio Pharma, ... | Sinha Uma | Chief Scientific Of ... | Option Exercise | A | 1.25 | 5,366 | 6,708 | 5,366 | |
May 21 2020 | BBIO | BridgeBio Pharma, ... | Sinha Uma | Chief Scientific Of ... | Grant | A | 0.00 | 1,523 | 0 | 15,523 | 14 K to 15.5 K (+10.88 %) |
May 21 2020 | BBIO | BridgeBio Pharma, ... | MCCORMICK FRANK | Chairman of Oncolog ... | Option Exercise | A | 1.05 | 10,549 | 11,076 | 10,549 | |
May 21 2020 | BBIO | BridgeBio Pharma, ... | MCCORMICK FRANK | Chairman of Oncolog ... | Grant | A | 0.00 | 39,042 | 0 | 1,300,568 | 1.3 M to 1.3 M (+3.09 %) |
May 06 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | See Remarks | Sell | S | 30.47 | 1,460 | 44,493 | 162,362 | 163.8 K to 162.4 K (-0.89 %) |
May 06 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 30.49 | 5,706 | 173,959 | 315,916 | 321.6 K to 315.9 K (-1.77 %) |
May 06 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 31.23 | 34,834 | 1,088,012 | 2,405,372 | 2.4 M to 2.4 M (-1.43 %) |
May 06 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 30.86 | 44,766 | 1,381,470 | 2,440,206 | 2.5 M to 2.4 M (-1.80 %) |
May 05 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 30.00 | 1,494 | 44,827 | 321,622 | 323.1 K to 321.6 K (-0.46 %) |
May 05 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 29.83 | 1,200 | 35,795 | 323,116 | 324.3 K to 323.1 K (-0.37 %) |
May 05 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 29.11 | 6,000 | 174,680 | 324,316 | 330.3 K to 324.3 K (-1.82 %) |
May 05 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | See Remarks | Sell | S | 30.01 | 1,320 | 39,613 | 163,822 | 165.1 K to 163.8 K (-0.80 %) |
May 05 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | See Remarks | Sell | S | 29.87 | 300 | 8,960 | 165,142 | 165.4 K to 165.1 K (-0.18 %) |
May 05 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | See Remarks | Sell | S | 29.19 | 2,285 | 66,693 | 165,442 | 167.7 K to 165.4 K (-1.36 %) |
Apr 29 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 17.00 | 2,000 | 34,000 | 278,000 | |
Apr 29 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Sell | S | 32.01 | 2,000 | 64,028 | 9,823 | 11.8 K to 9.8 K (-16.92 %) |
Apr 29 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 17.00 | 2,000 | 34,000 | 11,823 | 9.8 K to 11.8 K (+20.36 %) |
Apr 10 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 17.00 | 8,000 | 136,000 | 280,000 | |
Apr 10 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Sell | S | 27.04 | 8,000 | 216,358 | 9,823 | 17.8 K to 9.8 K (-44.89 %) |
Apr 10 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 17.00 | 8,000 | 136,000 | 17,823 | 9.8 K to 17.8 K (+81.44 %) |
Apr 09 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 25.48 | 1,805 | 45,983 | 2,565,372 | 2.6 M to 2.6 M (-0.07 %) |
Apr 07 2020 | BBIO | BridgeBio Pharma, ... | HOMCY CHARLES J | Chairman of Pharmac ... | Gift | G | 0.00 | 40,000 | 0 | 1,302,291 | 1.3 M to 1.3 M (-2.98 %) |
Apr 06 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 25.10 | 100 | 2,510 | 2,567,177 | 2.6 M to 2.6 M (0.00 %) |
Apr 06 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 25.09 | 200 | 5,018 | 2,567,277 | 2.6 M to 2.6 M (-0.01 %) |
Apr 03 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | See Remarks | Sell | S | 27.56 | 1,100 | 30,313 | 167,727 | 168.8 K to 167.7 K (-0.65 %) |
Apr 03 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | See Remarks | Sell | S | 26.51 | 1,441 | 38,199 | 168,827 | 170.3 K to 168.8 K (-0.85 %) |
Apr 03 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | See Remarks | Sell | S | 25.40 | 44 | 1,118 | 170,268 | 170.3 K to 170.3 K (-0.03 %) |
Apr 03 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 27.74 | 1,286 | 35,677 | 330,316 | 331.6 K to 330.3 K (-0.39 %) |
Apr 03 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 26.86 | 2,500 | 67,149 | 331,602 | 334.1 K to 331.6 K (-0.75 %) |
Apr 03 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 26.01 | 3,414 | 88,783 | 334,102 | 337.5 K to 334.1 K (-1.01 %) |
Apr 03 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 25.04 | 15,778 | 395,103 | 2,567,477 | 2.6 M to 2.6 M (-0.61 %) |
Apr 03 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 28.20 | 1,382 | 38,979 | 2,583,255 | 2.6 M to 2.6 M (-0.05 %) |
Apr 03 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 27.45 | 12,976 | 356,252 | 2,584,637 | 2.6 M to 2.6 M (-0.50 %) |
Apr 03 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 26.38 | 20,040 | 528,623 | 2,597,613 | 2.6 M to 2.6 M (-0.77 %) |
Apr 03 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 25.52 | 27,719 | 707,508 | 2,617,653 | 2.6 M to 2.6 M (-1.05 %) |
Mar 04 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remark | Sell | S | 33.31 | 290 | 9,660 | 337,516 | 337.8 K to 337.5 K (-0.09 %) |
Mar 04 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remark | Sell | S | 32.65 | 5,550 | 181,180 | 337,806 | 343.4 K to 337.8 K (-1.62 %) |
Mar 04 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remark | Sell | S | 31.79 | 4,960 | 157,701 | 343,356 | 348.3 K to 343.4 K (-1.42 %) |
Mar 04 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | See Remarks | Sell | S | 32.89 | 1,400 | 46,047 | 170,312 | 171.7 K to 170.3 K (-0.82 %) |
Mar 04 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | See Remarks | Sell | S | 32.20 | 2,575 | 82,918 | 171,712 | 174.3 K to 171.7 K (-1.48 %) |
Feb 14 2020 | BBIO | BridgeBio Pharma, ... | DANIELS RONALD J | Director | Option Exercise | A | 34.65 | 91,554 | 3,172,346 | 91,554 | |
Feb 14 2020 | BBIO | BridgeBio Pharma, ... | MOMTAZEE JAMES C | Director | Option Exercise | A | 34.65 | 24,927 | 863,721 | 24,927 | |
Feb 14 2020 | BBIO | BridgeBio Pharma, ... | MOMTAZEE JAMES C | Director | Grant | A | 0.00 | 8,491 | 0 | 8,491 | 0 to 8.5 K |
Feb 13 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 17.00 | 2,000 | 34,000 | 288,000 | |
Feb 13 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Sell | S | 37.28 | 2,000 | 74,564 | 9,823 | 11.8 K to 9.8 K (-16.92 %) |
Feb 13 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 17.00 | 2,000 | 34,000 | 11,823 | 9.8 K to 11.8 K (+20.36 %) |
Feb 12 2020 | BBIO | BridgeBio Pharma, ... | HOMCY CHARLES J | Chairman of Pharmac ... | Sell | S | 36.00 | 20,000 | 720,000 | 1,342,291 | 1.4 M to 1.3 M (-1.47 %) |
Feb 07 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 34.87 | 30,893 | 1,077,390 | 2,765,372 | 2.8 M to 2.8 M (-1.10 %) |
Feb 05 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | See Remarks | Sell | S | 34.55 | 54,951 | 1,898,387 | 2,796,265 | 2.9 M to 2.8 M (-1.93 %) |
Feb 05 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | See Remarks | Sell | S | 35.20 | 2,100 | 73,914 | 2,851,216 | 2.9 M to 2.9 M (-0.07 %) |
Feb 05 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | See Remarks | Sell | S | 34.92 | 32,056 | 1,119,309 | 2,853,316 | 2.9 M to 2.9 M (-1.11 %) |
Feb 05 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | See Remarks | Sell | S | 34.90 | 3,975 | 138,729 | 174,287 | 178.3 K to 174.3 K (-2.23 %) |
Feb 05 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 34.52 | 4,973 | 171,692 | 348,316 | 353.3 K to 348.3 K (-1.41 %) |
Feb 05 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 34.90 | 5,827 | 203,379 | 353,289 | 359.1 K to 353.3 K (-1.62 %) |
Jan 16 2020 | BBIO | BridgeBio Pharma, ... | HOMCY CHARLES J | Chairman of Pharmac ... | Option Exercise | M | 17.00 | 10,000 | 170,000 | 280,463 | |
Jan 16 2020 | BBIO | BridgeBio Pharma, ... | HOMCY CHARLES J | Chairman of Pharmac ... | Sell | S | 35.00 | 10,000 | 350,000 | 1,362,291 | 1.4 M to 1.4 M (-0.73 %) |
Jan 16 2020 | BBIO | BridgeBio Pharma, ... | HOMCY CHARLES J | Chairman of Pharmac ... | Buy | M | 17.00 | 10,000 | 170,000 | 1,372,291 | 1.4 M to 1.4 M (+0.73 %) |
Jan 10 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 17.00 | 10,000 | 170,000 | 290,000 | |
Jan 10 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Sell | S | 34.71 | 4,802 | 166,670 | 9,823 | 14.6 K to 9.8 K (-32.83 %) |
Jan 10 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Sell | S | 34.17 | 8,005 | 273,541 | 14,625 | 22.6 K to 14.6 K (-35.37 %) |
Jan 10 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 17.00 | 10,000 | 170,000 | 22,630 | 12.6 K to 22.6 K (+79.18 %) |
Jan 06 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | See Remarks | Sell | S | 32.88 | 6,668 | 219,250 | 2,885,372 | 2.9 M to 2.9 M (-0.23 %) |
Jan 06 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | See Remarks | Sell | S | 32.14 | 77,271 | 2,483,706 | 2,892,040 | 3 M to 2.9 M (-2.60 %) |
Jan 06 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | See Remarks | Sell | S | 35.17 | 100 | 3,517 | 2,969,311 | 3 M to 3 M (0.00 %) |
Jan 06 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | See Remarks | Sell | S | 34.19 | 5,077 | 173,560 | 2,969,411 | 3 M to 3 M (-0.17 %) |
Jan 06 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | See Remarks | Sell | S | 33.41 | 19,793 | 661,342 | 2,974,488 | 3 M to 3 M (-0.66 %) |
Jan 06 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | See Remarks | Sell | S | 32.55 | 11,091 | 361,042 | 2,994,281 | 3 M to 3 M (-0.37 %) |
Jan 06 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 32.31 | 3,536 | 114,246 | 359,116 | 362.7 K to 359.1 K (-0.98 %) |
Jan 06 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 31.94 | 100 | 3,194 | 362,652 | 362.8 K to 362.7 K (-0.03 %) |
Jan 06 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 35.17 | 30 | 1,055 | 362,752 | 362.8 K to 362.8 K (-0.01 %) |
Jan 06 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 34.23 | 622 | 21,293 | 362,782 | 363.4 K to 362.8 K (-0.17 %) |
Jan 06 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 33.47 | 4,217 | 141,156 | 363,404 | 367.6 K to 363.4 K (-1.15 %) |
Jan 06 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 32.57 | 2,295 | 74,739 | 367,621 | 369.9 K to 367.6 K (-0.62 %) |
Jan 06 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | See Remarks | Sell | S | 33.00 | 26 | 858 | 178,262 | 178.3 K to 178.3 K (-0.01 %) |
Jan 06 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | See Remarks | Sell | S | 32.28 | 332 | 10,717 | 178,288 | 178.6 K to 178.3 K (-0.19 %) |
Jan 06 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | See Remarks | Sell | S | 34.45 | 115 | 3,962 | 178,620 | 178.7 K to 178.6 K (-0.06 %) |
Jan 06 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | See Remarks | Sell | S | 33.61 | 2,002 | 67,291 | 178,735 | 180.7 K to 178.7 K (-1.11 %) |
Jan 06 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | See Remarks | Sell | S | 32.69 | 1,500 | 49,034 | 180,737 | 182.2 K to 180.7 K (-0.82 %) |
Dec 31 2019 | BBIO | BridgeBio Pharma, ... | MCCORMICK FRANK | Chairman of Oncolog ... | Sell | S | 36.86 | 900 | 33,172 | 1,261,526 | 1.3 M to 1.3 M (-0.07 %) |
Dec 31 2019 | BBIO | BridgeBio Pharma, ... | MCCORMICK FRANK | Chairman of Oncolog ... | Sell | S | 35.74 | 16,250 | 580,840 | 1,262,426 | 1.3 M to 1.3 M (-1.27 %) |
Dec 31 2019 | BBIO | BridgeBio Pharma, ... | MCCORMICK FRANK | Chairman of Oncolog ... | Sell | S | 42.93 | 100 | 4,293 | 1,278,576 | 1.3 M to 1.3 M (-0.01 %) |
Dec 31 2019 | BBIO | BridgeBio Pharma, ... | MCCORMICK FRANK | Chairman of Oncolog ... | Sell | S | 42.26 | 617 | 26,076 | 1,278,676 | 1.3 M to 1.3 M (-0.05 %) |
Dec 31 2019 | BBIO | BridgeBio Pharma, ... | MCCORMICK FRANK | Chairman of Oncolog ... | Sell | S | 41.31 | 883 | 36,480 | 1,279,293 | 1.3 M to 1.3 M (-0.07 %) |
Dec 31 2019 | BBIO | BridgeBio Pharma, ... | MCCORMICK FRANK | Chairman of Oncolog ... | Sell | S | 40.13 | 16,858 | 676,441 | 1,280,176 | 1.3 M to 1.3 M (-1.30 %) |
Dec 31 2019 | BBIO | BridgeBio Pharma, ... | MCCORMICK FRANK | Chairman of Oncolog ... | Sell | S | 39.27 | 13,705 | 538,236 | 1,297,034 | 1.3 M to 1.3 M (-1.05 %) |
Dec 31 2019 | BBIO | BridgeBio Pharma, ... | MCCORMICK FRANK | Chairman of Oncolog ... | Sell | S | 38.09 | 3,500 | 133,317 | 1,310,739 | 1.3 M to 1.3 M (-0.27 %) |
Dec 31 2019 | BBIO | BridgeBio Pharma, ... | MCCORMICK FRANK | Chairman of Oncolog ... | Sell | S | 36.85 | 21,656 | 797,937 | 1,314,239 | 1.3 M to 1.3 M (-1.62 %) |
Dec 31 2019 | BBIO | BridgeBio Pharma, ... | MCCORMICK FRANK | Chairman of Oncolog ... | Sell | S | 36.37 | 25,531 | 928,588 | 1,335,895 | 1.4 M to 1.3 M (-1.88 %) |
Dec 16 2019 | BBIO | BridgeBio Pharma, ... | SCHELLER RICHARD H | See Remarks | Option Exercise | A | 37.45 | 82,878 | 3,103,781 | 82,878 | |
Dec 16 2019 | BBIO | BridgeBio Pharma, ... | YAU YI CHING | Chief Accounting Of ... | Option Exercise | A | 0.00 | 55,652 | 0 | 55,652 | |
Dec 16 2019 | BBIO | BridgeBio Pharma, ... | Stolz Brian M. | Chief Operating Off ... | Option Exercise | A | 0.00 | 72,696 | 0 | 72,696 | |
Dec 16 2019 | BBIO | BridgeBio Pharma, ... | MOMTAZEE JAMES C | Director | Option Exercise | A | 37.45 | 82,878 | 3,103,781 | 82,878 | |
Dec 16 2019 | BBIO | BridgeBio Pharma, ... | AGUIAR ERIC | Director | Option Exercise | A | 37.45 | 82,878 | 3,103,781 | 82,878 | |
Dec 16 2019 | BBIO | BridgeBio Pharma, ... | HOMCY CHARLES J | Chairman of Pharmac ... | Option Exercise | A | 37.45 | 82,878 | 3,103,781 | 82,878 | |
Dec 16 2019 | BBIO | BridgeBio Pharma, ... | Cook Jennifer E. | Director | Option Exercise | A | 37.45 | 82,878 | 3,103,781 | 82,878 | |
Dec 16 2019 | BBIO | BridgeBio Pharma, ... | Satvat Ali J. | Director | Option Exercise | A | 37.45 | 82,878 | 3,103,781 | 82,878 | |
Nov 15 2019 | BBIO | BridgeBio Pharma, ... | Stolz Brian M. | Chief Operating Off ... | Option Exercise | A | 0.00 | 106,469 | 0 | 106,469 | |
Nov 15 2019 | BBIO | BridgeBio Pharma, ... | Stolz Brian M. | Chief Operating Off ... | Option Exercise | A | 26.28 | 102,081 | 2,682,689 | 102,081 | |
Nov 15 2019 | BBIO | BridgeBio Pharma, ... | Stolz Brian M. | Chief Operating Off ... | Grant | A | 0.00 | 22,839 | 0 | 22,839 | 0 to 22.8 K |
Nov 15 2019 | BBIO | BridgeBio Pharma, ... | YAU YI CHING | Chief Accounting Of ... | Option Exercise | A | 0.00 | 20,376 | 0 | 20,376 |